These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26710539)

  • 1. [In vitro susceptibility of isolates of Paracoccidioides spp complex to systemic antifungals using the microdilution method].
    Cermehol JR; Alvarado P; Mendoza M; Herndndez I; Cuestal D
    Invest Clin; 2015 Sep; 56(3):243-53. PubMed ID: 26710539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between broth microdilution and disk diffusion methods for antifungal susceptibility testing of caspofungin, voriconazole, amphotericin B, itraconazole and fluconazole against Candida glabrata.
    Kiraz N; Dag I; Oz Y; Yamac M; Kiremitci A; Kasifoglu N
    J Microbiol Methods; 2010 Aug; 82(2):136-40. PubMed ID: 20493911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of different media, incubation times, and temperatures for determining the MICs of seven antifungal agents against Paracoccidioides brasiliensis by microdilution.
    Cruz RC; Werneck SM; Oliveira CS; Santos PC; Soares BM; Santos DA; Cisalpino PS
    J Clin Microbiol; 2013 Feb; 51(2):436-43. PubMed ID: 23175254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro sensitivity of Paracoccidioides brasiliensis to systemically used antifungal agents].
    Rodero L; Canteros CE; Rivas C; Lee W; Davel G
    Rev Argent Microbiol; 1999; 31(2):78-81. PubMed ID: 10425663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp.
    Pfaller MA; Castanheira M; Messer SA; Rhomberg PR; Jones RN
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):198-204. PubMed ID: 24736096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
    Fleck R; Dietz A; Hof H
    J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microplate alamarBlue assay for Paracoccidioides susceptibility testing.
    de Paula e Silva AC; Oliveira HC; Silva JF; Sangalli-Leite F; Scorzoni L; Fusco-Almeida AM; Mendes-Giannini MJ
    J Clin Microbiol; 2013 Apr; 51(4):1250-2. PubMed ID: 23345296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
    Ozcan SK; Mutlu B; Dündar D; Willke A
    Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD; Kiraz N
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
    Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Sensititre YeastOne® dilution method with the Clinical Laboratory Standards Institute (CLSI) M27-A3 microbroth dilution reference method for determining MIC of eight antifungal agents on 102 yeast strains.
    Bertout S; Dunyach C; Drakulovski P; Reynes J; Mallié M
    Pathol Biol (Paris); 2011 Feb; 59(1):48-51. PubMed ID: 20843616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genotypes and in vitro antifungal susceptibility of Cryptococcus isolates in Sichuan Province].
    Lei Y; Xiao YL; He C; Zhang CY; Xie Y; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 46(1):82-6. PubMed ID: 25807801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
    Rojas FD; Sosa Mde L; Fernández MS; Cattana ME; Córdoba SB; Giusiano GE
    Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the microdilution, Etest and disk diffusion methods for antifungal susceptibility testing of clinical strains of Trichosporon spp.
    Metin DY; Hilmioglu-Polat S; Hakim F; Inci R; Tumbay E
    J Chemother; 2005 Aug; 17(4):404-8. PubMed ID: 16167520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
    Vivas JR; Torres-Rodríguez JM
    Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
    Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH
    Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Fothergill A; Ghannoum M; Manavathu E; Ostrosky-Zeichner L; Pfaller M; Rinaldi M; Schell W; Walsh T
    J Clin Microbiol; 2005 Oct; 43(10):5243-6. PubMed ID: 16207990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.